AK

Apeksh Krushnakant Patwa

Active Director Director DIN 01323343
DIN 01323343 First appointment Feb 2004 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 3 historical roles
Total affiliations 5 Since Feb 2004
Shareholding value •••• Premium profile

About Apeksh Krushnakant Patwa

Data last updated:

Apeksh Krushnakant Patwa is a Director at Deep Anaesthesia Associates Private Limited (since 2021) and Director at Vadodara Neurological Association (since 2015). The companies operate in Healthcare and Electrnoics. The 2 current companies with reported revenue have a combined latest revenue of ₹2.90 Cr; the largest is Deep Anaesthesia Associates Private Limited at ₹2.86 Cr (FY 2024). Earlier, Apeksh Krushnakant Patwa was a Designated Partner at Vinvent Tekmed Llp (2015–2025) and Director at Vins Hospital Private Limited (2004–2026) and 1 more.

DIN 01323343
Primary Designation Director
Industry Healthcare
First Appointment 09 Feb 2004
Oldest Company Age 11 yrs
Largest company Deep Anaesthesia Associates Private Limited · ₹2.86 Cr (FY 2024)
Combined revenue ₹2.90 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director07 Oct 20212021₹2.86 Cr (FY 2024)Active
Vadodara Neurological Association U85100GJ2015NPL082736
Director27 Mar 20152015₹4.4 Lakh (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner23 Dec 20152015Active
Vins Hospital Private Limited U85110GJ2004PTC043583
Director09 Feb 20042004₹16.47 Cr (FY 2024)Active
Pims Hospital Private Limited U85110GJ2007PTC050448
Director03 Apr 20072007₹38,384 (FY 2023)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Vadodara Neurological Association
Deep Anaesthesia Associates Private Limited
Vinvent Tekmed Llp
Vins Hospital Private Limited
Premium access

Shareholding and investment profile for Apeksh Krushnakant Patwa

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Apeksh Krushnakant Patwa

Apeksh Krushnakant Patwa currently holds 2 directorships: Deep Anaesthesia Associates Private Limited (Director, since 07 Oct 2021, revenue ₹2.86 Cr (FY 2024)); Vadodara Neurological Association (Director, since 27 Mar 2015, revenue ₹4.4 Lakh (FY 2025)).

Apeksh Krushnakant Patwa was first appointed on 09 Feb 2004 as Director at Vins Hospital Private Limited. The most recent appointment on record is 07 Oct 2021 at Deep Anaesthesia Associates Private Limited.

The 2 current companies of Apeksh Krushnakant Patwa that report revenue have a combined latest revenue of ₹2.90 Cr: Deep Anaesthesia Associates Private Limited ₹2.86 Cr (FY 2024); Vadodara Neurological Association ₹4.4 Lakh (FY 2025).

Apeksh Krushnakant Patwa held 3 earlier board appointments: Vinvent Tekmed Llp (Designated Partner, 23 Dec 2015 to 11 Jul 2025); Vins Hospital Private Limited (Director, 09 Feb 2004 to 06 Feb 2026); Pims Hospital Private Limited (Director, 03 Apr 2007 to 27 Apr 2021).

The current boards of Apeksh Krushnakant Patwa's companies include Amit Pravinchandra Shah (Deep Anaesthesia Associates Private Limited), Anant Murlidhar Rane (Deep Anaesthesia Associates Private Limited), Ashish Bhogilal Shah (Deep Anaesthesia Associates Private Limited), Harshalkumar Vinodchandra Dave (Deep Anaesthesia Associates Private Limited), Minesh Khimjibhai Barochia (Deep Anaesthesia Associates Private Limited), Miteshkumar Bharatkumar Shah (Deep Anaesthesia Associates Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available